Literature DB >> 22812593

Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor.

Eric Simpson1, Arne Böhling, Stephan Bielfeldt, Catherine Bosc, Nabil Kerrouche.   

Abstract

BACKGROUND: Atopic dermatitis (AD) is characterized by barrier abnormalities, including insufficient ceramides in the stratum corneum (SC).
OBJECTIVE: To measure the effects of a new moisturizer (CRM) containing a ceramide precursor in improving skin barrier function in patients with controlled atopic dermatitis.
METHODS: In this randomized, intra-individual comparison, investigator-blinded study, CRM was applied to the test area of one lower leg for 27 days (the other leg remained as untreated control). Evaluations at baseline and day 28 included transepidermal water loss (TEWL), skin hydration by corneometry, dryness severity, Raman spectroscopy, and collection of adverse events.
RESULTS: After 4 weeks of treatment, results showed a significantly greater reduction of TEWL and clinical dryness scores, and increased skin hydration (all p < 01) in the CRM-treated than untreated area. A significantly higher level of ceramide (p < 05) and a trend toward increased water content was observed with Raman in the SC for CRM than for the control. There were no related AEs.
CONCLUSION: Skin barrier function and hydration were significantly improved after CRM treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22812593     DOI: 10.3109/09546634.2012.713461

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  15 in total

Review 1.  The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2013-12

Review 2.  Moisturizing different racial skin types.

Authors:  Derrick C Wan; Victor W Wong; Michael T Longaker; George P Yang; Fu-Chan Wei
Journal:  J Clin Aesthet Dermatol       Date:  2014-06

3.  A topical heparinoid-containing product improves epidermal permeability barrier homeostasis in mice.

Authors:  Ye Yao; Pan Guo; Xiaoyue Feng; Chunping Shen; Junkai Huang; Jiechen Zhang; Peter M Elias; Lizhi Hu; Mao-Qiang Man
Journal:  Exp Dermatol       Date:  2019-07-04       Impact factor: 3.960

Review 4.  Emerging targets in lipid-based therapy.

Authors:  Stephanie C Tucker; Kenneth V Honn
Journal:  Biochem Pharmacol       Date:  2012-12-20       Impact factor: 5.858

Review 5.  Emollients and moisturisers for eczema.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Robin Christensen; Adriana Lavrijsen; Bernd WM Arents
Journal:  Cochrane Database Syst Rev       Date:  2017-02-06

6.  Local rhamnosoft, ceramides and L-isoleucine in atopic eczema: a randomized, placebo controlled trial.

Authors:  Alessia Marseglia; Amelia Licari; Fabio Agostinis; Antonio Barcella; Domenico Bonamonte; Mario Puviani; Massimo Milani; GianLuigi Marseglia
Journal:  Pediatr Allergy Immunol       Date:  2014-05       Impact factor: 6.377

Review 7.  Performance and Tolerability of the Moisturizers Cetaphil® and Excipial® in Atopic Dermatitis: What is the Evidence Based on Randomized Trials?

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Bernd W M Arents
Journal:  Dermatol Ther (Heidelb)       Date:  2017-06-09

8.  The efficacy of a pseudo-ceramide and eucalyptus extract containing lotion on dry scalp skin.

Authors:  Yutaka Takagi; Xuanhe Ning; Akihiko Takahashi; Chiaki Ishizaki; Takahiro Nishizaka; Kazuhiro Kaizu; Masahiro Miyaki; Hotaka Yamamuro; Makoto Kawashima
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-04-06

9.  A consistent skin care regimen leads to objective and subjective improvements in dry human skin: investigator-blinded randomized clinical trial.

Authors:  Sooyoung Kim; Baochau K Ly; Judy H Ha; Kathryn A Carson; Stacy Hawkins; Sewon Kang; Anna L Chien
Journal:  J Dermatolog Treat       Date:  2021-06-22       Impact factor: 3.359

10.  Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis.

Authors:  Martin Glatz; Jay-Hyun Jo; Elizabeth A Kennedy; Eric C Polley; Julia A Segre; Eric L Simpson; Heidi H Kong
Journal:  PLoS One       Date:  2018-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.